Pembrolizumab (for recurrent/metastatic NPC)
Treatment used for 1 condition
Total Trials
3
Total Participants
5K
Avg Effectiveness
65%
Avg Safety Score
45%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.